A new analysis of medical research shows potential benefits of nutrient supplements for treatment and prevention of mental illnesses including depression and schizophrenia.
In a paper recently published in World Psychiatry, the official journal of the World Psychiatric Association, researchers analysed 33 previous studies investigating the effectiveness and safety of nutritional supplements in the treatment of common and severe mental illness.
PUFAs (polyunsaturated fatty acids, which includes omega 3) showed the strongest evidence as being beneficial for depression and attention deficit/hyperactivity disorder.
Folates showed promise in the treatment of depression and schizophrenia, while N‐acetylcysteine (NAC) may benefit mood disorders and schizophrenia.
Crucially, all of the nutrient supplements had good safety profiles, with no evidence of serious adverse effects or issues with psychiatric medications.